| Trial ID: | L4712 |
| Source ID: | NCT00320021
|
| Associated Drug: |
Pyridorin (Pyridoxamine Dihydrochloride)
|
| Title: |
Effect of Pyridorin in Patients With Diabetic Nephropathy
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetic Nephropathy
|
| Interventions: |
DRUG: Pyridorin (pyridoxamine dihydrochloride)
|
| Outcome Measures: |
Primary: Change in Serum Creatinine from baseline to week 26 |
|
| Sponsor/Collaborators: |
Sponsor: BioStratum
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
80
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2002-07
|
| Completion Date: |
2003-09
|
| Results First Posted: |
|
| Last Update Posted: |
2006-04-27
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00320021
|
